Antivirals

As per available reports about 713 journals, 74 Conferences, 8 workshops are presently dedicated exclusively to Antivirals and about 38291 articles are being published on the subject Antivirals. In terms of research annually, USA, India, Japan, UK, Ireland and Kenya are some of the leading countries where maximum studies related to Antivirals are being carried out. Antivirals are drugs used to treat viral infections. Antivirals inhibit the development of the virus. They are a class of antimicrobials and are harmless to the host. A virus is a genetic material made if either DNA or RNA enclosed in a protein coat, and requires host machinery to replicate. Without the host a virus is dormant. Hence it is difficult to design antivirus that acts effectively on a virus.


The Journal of Antivirals & Antiretrovirals is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Antiretroviral Therapy. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Antivirals & Antiretrovirals provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Antiretroviral Therapy, thus bridging the gap between researchers and young scientists.

OMICS Group, the world pioneer for organizing 150 International conferences in USA, Europe, Asia and other continents. Uniquely, 350 peer-reviewed open access journals were operating by OMICS Publishing Group. This will reflect the scope in current research and development in science, healthcare and technology. With a strong intention to accelerate the scientific discovery, OMICS Group International has been associated with more than150 scientific Societies and Associations.